By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


Start Up

Company News
Regulus (RGLS) Announces Timing For First Quarter 2016 Financial Results Webcast And Conference Call 4/26/2016 3:31:34 PM
Regulus (RGLS) Presents Additional Interim Data On RG-101 At International Liver Congress (ILC 2016) 4/15/2016 6:15:15 AM
Regulus (RGLS) To Present New RG-101 Data At The International Liver Congress 2016 (ILC 2016) 3/16/2016 6:34:41 AM
Regulus (RGLS) Reports Fourth Quarter And Year-End 2015 Financial Results And Recent Highlights 2/23/2016 7:53:29 AM
Instead of AbbVie (ABBV) and Merck & Co. (MRK), Gilead (GILD) Should Fear Tiny Upstart Regulus (RGLS) 2/22/2016 7:27:43 AM
Regulus (RGLS) Announces Timing For Fourth Quarter And Year-End 2015 Financial Results Webcast And Conference Call 2/18/2016 6:49:15 AM
Regulus (RGLS) Soars After Promising Hep C Drug Trial Data 2/17/2016 6:03:01 AM
Regulus (RGLS) Completes RG-101 Enrollment In Phase II Combination Study 1/21/2016 6:27:53 AM
Regulus (RGLS) Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 1/7/2016 7:00:15 AM
Regulus (RGLS) Release: RG-125(AZD4076), A microRNA Therapeutic Targeting microRNA-103/107 Being Developed For The Treatment Of NASH In Patients With Type 2 Diabetes/Pre-Diabetes, Enters Phase I Clinical Development 12/18/2015 6:52:43 AM